Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2013
10/03/2013US20130261118 Compounds for alzheimer's disease
10/03/2013US20130261081 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
10/02/2013EP2644607A1 Oxygenated fused ring derivative and organic electroluminescence element containing the same
10/02/2013EP2644601A1 Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof
10/02/2013EP2644600A1 Heterocyclic aspartyl protease inhibitors
10/02/2013EP2644595A1 N-Cyclylamides as nematicides
10/02/2013EP2643314A1 Novel salts and polymorphic forms of afatinib
10/02/2013EP2643302A1 Insecticidal compounds
10/02/2013EP2643299A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
10/02/2013CN103339139A 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
10/02/2013CN103339123A Indeno- fused ring compounds having photochromic properties
10/02/2013CN103339111A Bicyclic acetyl-CoA carboxylase inhibitors
10/02/2013CN103339110A Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
10/02/2013CN103333170A 苯并咪唑类化合物及其用途 Benzimidazole compounds and their uses
10/02/2013CN103333163A Coumarone derivative, and preparation method and applications thereof
10/02/2013CN103333162A 病毒聚合酶抑制剂 Viral polymerase inhibitors
10/02/2013CN103333161A Preparation method and use of 1'-oxo-indirubin
10/02/2013CN103333122A Pinanyl-2-aminopyrimidine compounds as well as synthesis and application thereof
10/02/2013CN103333097A Synthesis method of diindolylmethane derivatives
10/02/2013CN102351849B Preparation method of olmesartan medoxomil
10/02/2013CN102186818B 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
10/02/2013CN101679251B (Aza)indole derivative and use thereof for medical purposes
10/01/2013US8546576 3 or 4-substituted piperidine compounds
10/01/2013US8546569 Chemical compounds
10/01/2013US8546429 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013US8546405 Anti-viral compounds
10/01/2013US8546403 Compounds that modulate intracellular calcium
10/01/2013US8546402 Chromone derivatives, a process for their preparation and their therapeutic applications
10/01/2013US8546401 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
10/01/2013US8546398 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/01/2013US8546376 Pharmaceutical compounds
10/01/2013US8546374 Amino-tetrazoles analogues and methods of use
10/01/2013CA2735844C Use of piperine and analogues thereof in the prevention of skin cancer
10/01/2013CA2532152C Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
09/2013
09/26/2013WO2013142326A1 5-carbonylamino-/(sulfonamido-) substituted benz imidazoles and use thereof treatment of tuberculosis
09/26/2013WO2013142307A1 Carbamate compounds and of making and using same
09/26/2013WO2013141586A1 Novelpyridopyrimidine derivatives and use thereof
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
09/26/2013WO2013140148A1 Quinazoline compounds and their use in therapy
09/26/2013WO2013139987A1 Chemical process for preparing spiroindolones and intermediates thereof
09/26/2013WO2013139949A1 Compositions comprising a strigolactame compound for enhanced plant growth and yield
09/26/2013WO2013139929A1 Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
09/26/2013WO2013139487A1 Flavone derivatives and their use
09/26/2013WO2013139426A1 Process for preparing benzo[1,2-b;4,5-b']dithiophene-4,8-dicarboxylic acid or its 2,3-dihydro derivative
09/26/2013WO2013139206A1 3-oxo-3,4-dihydro-2-pyrazine-formamide derivative, pharmaceutical composition of same, method for preparing same, and use thereof
09/26/2013US20130253186 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
09/26/2013US20130253010 Modulators of Aldhehyde Dehydrogenase Activity and Methods of Use Thereof
09/26/2013US20130253008 Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereof
09/26/2013US20130253005 Small molecule inhibitors of usp1 deubiquitinating enzyme activity
09/26/2013US20130252984 Sulfur derivatives as chemokine receptor modulators
09/26/2013US20130252975 Novel rock inhibitors
09/26/2013US20130252974 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists
09/26/2013US20130252973 Benzofuranyl Derivatives
09/26/2013US20130252957 Pyridinone antagonists of alpha-4 integrins
09/26/2013US20130252955 (aza)indole derivative and use thereof for medical purposes
09/26/2013US20130252940 c-Met Modulators and Method of Use
09/26/2013US20130252937 New indanyloxydihydrobenzofuranylacetic acids
09/26/2013US20130252934 Serine/threonine kinase inhibitors
09/26/2013US20130252815 Roseobacticides and uses thereof
09/26/2013US20130251647 Low molecular weight modulators of the cold menthol receptor trpm8 and use thereof
09/26/2013US20130251631 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
09/25/2013EP2641906A1 Tofa analogs useful in treating dermatological disorders or conditions
09/25/2013EP2641902A1 Substituted pyrimidine ammonia compound and use thereof
09/25/2013EP2640720A2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
09/25/2013EP2640719A2 Antiviral compounds
09/25/2013EP2640709A2 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
09/25/2013EP2640707A1 5-halogenopyrazolecarboxamides
09/25/2013EP2640704A1 Nampt inhibitors
09/25/2013EP2640701A2 Cyanoenamines and their use as fungicides
09/25/2013CN103328467A Hydantoin derivatives useful as KV3 inhibitors
09/25/2013CN103328447A Compounds as c-Met kinase inhibitors
09/25/2013CN103328442A Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
09/25/2013CN103325950A Charge transport layers and films containing the same
09/25/2013CN103319469A Triglycidyl isocyanurate production method
09/25/2013CN103319468A Substituted spirobicyclic compounds, and application method and applications thereof
09/25/2013CN103319467A 4-[5-hydroxy-pyrone-2-ylmethyleneanimo]-3-sulfydryl-1,2,4-triazole compound and application thereof
09/25/2013CN103319466A 1,2,3-triazole-amino dithioformate compounds containing coumarin parent nucleus and preparation method and application thereof
09/25/2013CN103319465A Hantzsch ester derivative as well as preparation and application thereof
09/25/2013CN103319464A 病毒聚合酶抑制剂 Viral polymerase inhibitors
09/25/2013CN103319461A Preparation method of olmesartan medoxomil intermediate and synthesis method of olmesartan medoxomil
09/25/2013CN103319408A Compounds for preventing and treating cardiovascular diseases
09/25/2013CN102349873B Pharmaceutical compositions based on idazoxan salt or one of polymorphs thereof
09/25/2013CN102321080B Doxazosin mesylate V form crystal, and preparation method and usage thereof
09/25/2013CN102260250B (-) doxazosin mesylate type IV crystal as well as preparation method and application thereof
09/25/2013CN102131794B 6-substituted phenoxychroman carboxylic acid derivatives
09/25/2013CN101711242B ((Bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
09/25/2013CN101676268B Frangible compounds for pathogen inactivation
09/24/2013US8541453 Modulators of ATP-binding cassette transporters
09/24/2013US8540966 Contrast agents endowed with high relaxivity
09/24/2013CA2722028C 5-hydroxypyrimidine-4-carboxamide compound
09/24/2013CA2640652C Novel coumarin derivative having antitumor activity
09/24/2013CA2615866C 4-chromenonyl-1,4-dihydropyridines and their use
09/24/2013CA2615855C 4-chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof
09/24/2013CA2568914C Therapeutic agents, and methods of making and using the same
09/24/2013CA2557645C Caspase inhibitors and uses thereof
09/24/2013CA2474277C 2,4-pyrimidinediamine compounds and their uses
09/19/2013WO2013138617A1 3,5-diaminopyrazole kinase inhibitors
09/19/2013WO2013138613A1 3,5-diaminopyrazole kinase inhibitors
09/19/2013WO2013135648A1 Substituted pyrrolidine-2-carboxamides
09/19/2013WO2013135176A1 Aminoquinazoline derivative and use thereof in preparing anti-malignant tumor medicament
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 694